BTX306

Overview

BTX306 is a cereblon -targeting molecular glue degrader. BTX306 reduces myeloma cell viability and induces apoptosis . BTX306 overcomes myeloma cell resistance to Lenalidomide ( HY-A0003 ) or Bortezomib ( HY-10227 ). BTX306 is active against primary myeloma cells, and shows efficacy in vivo. BTX306 can be used for myeloma research.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > PROTAC | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > Molecular Glues | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Caspase

Product Information

• Catalog No.: HY-177740
• CAS No.: 2230747-62-1
• Molecular Formula: C20H19ClN4O4S
• Molecular Weight: 446.91
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source